Cipher Pharmaceuticals starts launch of new acne drug in U.S.
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne
Writer & Business Reporter
Articles and features originally published on Star Media Group’s hyperlocal, subscription-based business news service.
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne
Mississauga food truck fans are in luck this weekend. Two different events happening at the Ramada Plaza Airport Hotel and Celebration Square will be featuring the popular specialty vehicles on Saturday
Airport hotel and restaurant rolling out the welcome astroturf to attract football fans
Sheridan College’s Jeff Zabudsky hopes to develop a satellite campus in China in a few years and is on a trade mission to forge closer ties with Chinese educators
With a looming $1.5 billion budget deficit on the horizon, the city of Mississauga has put out the call for a new company to manage its collection agency services for the next five years
Mississauga drug company Cipher Pharmaceuticals Inc. has received Health Canada approved for its new acne drug Epuris
One of Mississauga’s biggest humanitarian groups is urging Canadians to be generous this holiday season in spite of the sluggish economy
A Mississauga-based drug research venture owned by two of the world’s biggest drugmakers says it has promising results from early tests on a new HIV drug
Cloud computing is gaining in popularity but Mississauga companies need to choose wisely which, if any, program to use
Despite an increase in production permits, studio occupancies and interest from the film and television industry in Mississauga, local businesses are still waiting to see a boost in their bottom line